Morgans analyst Scott Power maintained a Hold rating on Sigma Healthcare Ltd (S5YA – Research Report) today and set a price target of ...
At an industry level, our long-term stance remains cautious. The nondiscretionary nature of pharmaceuticals and other health-related products, coupled with ageing of the general population, implies ...
Resilient performance during the half is falling on deaf ears today. The post Sigma share price retreats as profits plunge 67 ...
To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...